Work

Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials

Year: 2024

Type: article

Source: The Lancet Rheumatology

DOI: 10.1016/s2665-9913(23)00341-7

Authors: Marthe Kirkesæther Brun, Johanna E Gehin, Kristin Hammersbøen Bjørlykke, David John Warren, Rolf A Klaasen, Joseph Sexton, Øystein Sandanger, Tore K Kvien, Cato Mørk, Jørgen Jahnsen, Nils Bolstad, Kristin Kaasen Jørgensen, Espen A Haavardsholm, Guro Løvik Goll, Silje Watterdal Syversen

Institutions: University of Oslo, Diakonhjemmet Hospital, Oslo University Hospital, Akershus University Hospital

Language: English

Topic: Biosimilars and Bioanalytical Methods

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Helse Sør-Øst RHF

OpenAlex ID: W4392022425

FWCI: 3.787

Cites: 31

Cited by: 26

Related to: 10